Technology, Life Sciences and Clean Energy COVID-19 Resources

Our Technology, Life Sciences and Clean Energy services group has compiled articles and resources to help businesses find the needed information to assist them in navigating the COVID-19 crisis.

Stay Current on the Latest COVID-19 Updates. Sign up for our newsletter today.

Technology, Life Sciences and Clean Energy COVID-19 Resources

Our Technology, Life Sciences and Clean Energy services group has compiled articles and resources to help businesses find the needed information to assist them in navigating the COVID-19 crisis.

Along with other businesses, those in the Technology, Life Sciences and Clean Energy industries have been thrust into the great unknown amid the extraordinary amount of disruption caused by the global outbreak of the Coronavirus Disease. To assist in navigating these turbulent times, our team of experts have created and compiled several resources to help you tackle these challenges while continuing to meet the needs of your customers.

COVID-19 Insights

COVID-19 Toolkits

COVID-19 Webinars

Trending Articles

Technology

Coronavirus (COVID-19): impact on the global tech goods & services industry
As soon as the severity of the coronavirus (COVID-19) in China was understood, it was clear that the virus was going to have a significant impact on the global tech industry. China is a major manufacturing center with facilities producing parts and components and pumping them through the global supply chain. It is difficult to predict what the final impact will be. However, early analysis predicts overall growth in the tech goods and services sector being limited to two percent to be probable, or a contraction of two percent in a pessimistic scenario. read on

The worst of COVID-19 impacts may be behind many tech companies
Ahead of Apple’s July 30 earnings report, a number of technology companies have reported better-than-expected earnings amid broader economic uncertainty due to COVID-19. The global coronavirus health crisis has had a profound impact on the way that most companies operate. While the pandemic battered tech stocks earlier in 2020, but for many companies, the worst of the impacts appear to be behind them. read on

Covid-19’s Impact On The Future Of IT Budgets
Despite IT spending’s downturn, spending on remote working apps and platforms is projected to reach double-digit growth rates this year. Gartner’s latest forecasts reflect how IT spending for remote working is a growth catalyst for public cloud services, predicted to grow 19% this year. Cloud-based telephony and messaging and cloud-based conferencing are also predicted to grow 8.9% and 24.3% respectively. read on

What comes after Zoom fatigue
It’s well over 100 days into the Covid-19 crisis, and I have to make a confession: I hate doing everything over video chat. I hated it at the start, and I hate it in new ways now. You’ve probably heard of “Zoom fatigue.” I’ve transcended Zoom fatigue. At this stage in the pandemic, I’m experiencing something more advanced, like that moment on a long run when you’ve fought through fatigue, tapped into your body’s store of endorphins, and also lost a toenail. read on

COVID-19: Post-Coronavirus technology trends
When we published Accenture’s 2020 Technology Vision report, COVID-19 was not yet a global pandemic. Now, it’s the greatest challenge the world has faced in decades. In just a few short months, it’s transformed people’s lives on an unprecedented scale, impacted every industry, and altered the course of companies’ growth. But the pandemic has not slowed innovation—it’s amplifying it to historic levels. read on

Why tech didn’t save us from covid-19
Technology has failed the US and much of the rest of the world in its most important role: keeping us alive and healthy. As I write this, more than 380,000 are dead, the global economy is in ruins, and the covid-19 pandemic is still raging. In an age of artificial intelligence, genomic medicine, and self-driving cars, our most effective response to the outbreak has been mass quarantines, a public health technique borrowed from the Middle Ages.  read on

Covid-19 Opens the Door for Gig Workers to Win Sick Pay
Uber, Lyft, and others have agreed to pay people who’ve missed work because of the virus. Seattle is on the cusp of making it law in that city. read on

The Pandemic Could Change Air Travel Forever
Airlines are weighing a return to a (socially distanced) sky, but the pandemic may reshape the future of flying. read on

3 Big SaaS Challenges for IT
As enterprises continue the inexorable move from on-premises to cloud applications, make sure your organization meets these three challenges head-on. read on

How Big Tech Is Setting the Work-From-Home Standard
Silicon Valley loves its disruption. If any industry was prepared to handle the monumental changes brought on by the coronavirus, it’s big tech. Companies like Twitter and Facebook were some of the first to require their employees to work from home, even before official shelter-in-place orders went into effect. Now, they and others have extended their remote work policies to allow their employees to telecommute from home forever, even after the pandemic ends. read on

Office work will never be the same
The pandemic brought us more meetings, longer hours, and remote everything. read on

11 best practices for Microsoft Teams video meetings
Here’s what to do before, during and after leading a video call in Microsoft Teams to ensure a beneficial experience for all. read on

The Apple-Google Contact Tracing Plan Won’t Stop COVID Alone
Putting the privacy of these smartphone apps aside, few Americans have been tested—and there’s a risk of false positives … read on

Rules Rewritten: Managing Data Centers Through the Pandemic
The world’s data center operators have made big operating adjustments. Some of these changes may stick around post-crisis … read on

Tech companies are crucial players in the coronavirus response. Are they contributing what’s most needed?
They’re donating millions of masks from their stockpiles. They’re teaming up with hospitals to share and analyze data. And they’re offering up their computing capabilities to help researchers. Tech companies large and small are coming forward as crucial players in the response to the coronavirus crisis. read on

Managing the Commercial Impact of the Coronavirus: Implications for the Technology Industry
The coronavirus (also known as COVID-19) has now been documented in more than 100 countries and territories. As the coronavirus outbreak continues to wreak havoc on markets and industries in the U.S. and around the world, businesses are now confronting significant and unique challenges. read on

The Asian Tech Industry’s Coronavirus Response: Now and the Future
The coronavirus outbreak throughout Asia has disrupted operations and upended 2020 plans for many technology companies, given the industry’s heavy concentration of manufacturing bases and customers in China and nearby countries. read on

life sciences

Full Economic Impact of COVID-19 on Life Sciences Industry Still Uncertain
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow. read on

Reshaping Trends In Life Sciences Industry: Top Companies, New Norms, COVID-19 Impact, Competitive Landscape & Forecast 2021-2027
Life Sciences Market report states the fundamental strategies, opportunities, drivers & dynamics that will lead to sustainable development in Life Sciences Industry. Our reports updated as per June 2020, Life Sciences Market Status with COVID-19 impact on the availability of raw materials, supply, consumer demand, new technologies, & changing business policies in this Industry are studied on detail. The report analyzes the existing and emerging top companies in Life Sciences. read on

Emerging risks in the life sciences industry and how to defend against them
Life sciences companies are confronting new challenges brought on by rapid economic and employment growth. read on

Controversy as pharma execs predict profits from COVID-19 vaccines
Concerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they expect to make profits from their products in evidence to a US Congressional panel. Moderna, Merck & Co, and Pfizer said they expect to profit from coronavirus vaccines if they are approved, although AstraZeneca and Johnson & Johnson said they will price their respective vaccines only to cover costs if they are approved. read on

Leading And Managing Change During A Time Of Transition And Cultural Transformation
The COVID-19 pandemic is representative of the complexity of the pharmaceutical and biotech industries, reinforcing the need for innovation, adaptability, and accountability as we work to meet the needs of today’s healthcare professionals and patients. While strategic leadership during times of transition and transformation can be especially challenging, consistently prioritizing organizational goals and strategies is paramount to success. read on

Helping Managers Navigate Through The “New Normal”
When our entire workforce, save a subset of bench scientists needed in the lab, began working from home (WFH) because of COVID-19, we knew that thoughtful leadership would be essential to ensure that productivity and wellness remained high. read on

Digital Health Predicted as the New Normal in COVID Aftermath
The most successful efforts so far show that collaboration is essential. And to that end, health technology companies are key players, helping to connect disparate resources, services, and information. The groundwork laid for more than 15 years by the digital health sector has suddenly become a critical asset. Here we’ll explore how virtual care, behavioral health, and data uses are responding to the pandemic and their lasting impact long after the crisis has been abated. read on

7 Lessons in Supply Chain Management Learned from COVID-19
Whether you are sourcing APIs, excipients, medical devices, drugs, or bed capacity in hospitals, your supply chain is key to delivering successful outcomes. The age-old challenge is to balance capacity vs. demand; however, as a result of the current coronavirus (COVID-19), we find ourselves deficient yet again. But introspection opens the doors to learning. So what did we miss? Where did we go wrong? Here are seven lessons in supply chain management we’ve learned early (article written in late March 2020) in this pandemic. read on

A Post-Covid New Normal in Healthcare
COVID 19 has shed new light on the term “national security” and laid bare our vulnerabilities as a people. Ken Rogoff, a Harvard economist, recently likened our situation to the Wizard of Oz “where Dorothy got sucked up in the tornado with her house, and it’s spinning around and you don’t know where it will come down”. Though he was speaking for the economy, the analogy is apt for our healthcare system as well—we are all more than dizzy now. However, we can expect that as our house lands from this pandemic, we will see our healthcare landscape differently and go about the hard work of a health system reset— read on

How COVID-19 is changing the sales model
The COVID-19 pandemic means that reps can no longer speak face-to-face with physicians and many HCPs simply don’t have the time to engage with pharma. As part of eyeforpharma Virtual we spoke with Florent Edouard, senior vice president and global head of commercial excellence at the Grünenthal group, and Jan van den Burg, vice president for commercial strategy at Veeva Europe, to get their thoughts on the changing situation and hear how Grünenthal adapted quickly to a virtual sales model. read on

What pharma can do to win in virtual
Early data indications from the first virtual congresses shows big changes are needed. As the life science industry is bracing itself for a prolonged period with minimal in-person meetings, what can the data from the first few months in lockdown tell about how best to navigate this future? read on

5 Biopharma Execs Reveal Corporate Culture Best Practices
“Corporate culture will soon be the number one reason why an employee stays or leaves a company.” read on

WHO: More than 70 COVID-19 Vaccines are in Development, Three in Clinical Trials
More than 2 million people have been diagnosed with COVID-19, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization (WHO), there are now more than 70 potential vaccines under development, with three already in clinical trials …  read on

Coronavirus news roundup April 9, 2020
As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to find new drugs, therapies and tests in the effort to bring the pandemic under control. We round up the latest R&D, digital health, events and business stories about coronavirus over the past week … read on

Biopharma Industry News: Update on the Novel Coronavirus
As the number of diagnosed cases of COVID-19 continues to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine … read on

Massachusetts life-sciences industry at forefront of worldwide fight against coronavirus
As Massachusetts braces for a surge of patients infected with the coronavirus, the state is playing an outsize role in the global fight against the pandemic. Companies in the state are scrambling to develop and distribute potential vaccines, drugs, and diagnostic tests. Researchers at Harvard University, the Massachusetts Institute of Technology, and other schools are studying everything from genetic resistance to the virus to whether better face masks can be designed to protect people. read on

The coronavirus could help pharma reset its reputation in Washington
The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington. Already, the fervid crusade to contain the epidemic refocused a White House meeting centered on high drug prices onto the industry’s ostensibly more commendable work to develop vaccines and therapies that target the virus. And there are early indications the industry is leveraging the shift in the conversation … read on

clean energy

COVID-19 Is Accelerating the Clean Energy Transition
It’s often easy to lose sight of any silver linings associated with the COVID-19 pandemic. However, one trend that’s worth noting relates to how this global public health crisis could speed the transition to clean, renewable energy. A new report from Lux Research predicts trillions of dollars from economic relief packages to go into deploying low- and zero-carbon infrastructure. The money could also enable more investigations into and development of the technologies that make such improvements possible.  read on

The impact of the Covid-19 crisis on clean energy progress
The Covid-19 pandemic is having a major impact on energy systems around the world, curbing investments and threatening to slow the expansion of key clean energy technologies. read on

Companies press for renewables support in COVID-19 recovery package, but near-term effects in doubt
American corporations want the post-pandemic recovery to be a green recovery. Renewable energy could indeed play a role in the recovery from COVID-19, analysts say, but the details of the plan will determine its success. read on

Throughout COVID-19 recovery, ‘plummeting’ clean energy costs can help climate action
As COVID-19 hits the fossil fuel industry, a new UN report published on Wednesday shows that renewable energy is more cost-effective than ever – providing an opportunity to prioritize clean energy in national economic recovery packages and bring the world closer to meeting the goals of the Paris Agreement. read on

‘It’s still too soon to say Covid is a tipping point for renewables’
The International Energy Agency (IEA) created a global stir in May when it warned that the Covid-19 pandemic will lead to “the largest drop in global energy investment in history”, with spending to plunge this year in every area from fossil fuels to renewables and energy efficiency. But behind the headlines – many of them far more positive for renewables than other energy sectors – the picture is more nuanced. read on

World Energy Council sees 350,000 energy jobs at risk on Covid-19
The Covid-19 pandemic is prompting energy companies world-wide to shed jobs and cut costs, and will have a fundamental impact on the pace and direction of global energy transition, the World Energy Council (WEC) said, pointing to the latest findings of its global surveys. “The Covid-19 crisis is triggering the greatest financial capital re-allocation in history. No-one can predict the future,” the council’s secretary general, Angela Wilkinson, said. read on

How Covid-19 is helping solve one of the renewable energy’s biggest problems
The inertia required to keep grids stable — in the past supplied by conventional power plant turbines — is falling as lower electricity demand increases how much wind and solar is on networks. System operators need to adopt new solutions, writes Chris Kimmett read on

Will Covid-19 mark a permanent shift in oil companies’ energy-transition strategies?
Peak oil may have already been reached, say supermajor bosses as they cut hydrocarbons spending and double down on clean-energy plans read on

Global solar growth slides 18% as Covid-19 hits market: WoodMac
Analyst group revises 2020 forecast down to 106GW over unprecedented impact from coronavirus lockdowns read on

Energy Storage Industry Expected to Rebound in 2021
Despite the current COVID-19 pandemic, the medium-term future for the global energy storage industry remains bright. read on

COVID-19 Stunts Solar Job Growth
The U.S. solar industry will employ 114,000 fewer workers by June, compared to previous forecasts that projected the industry would employ 302,000 Americans over the same time period. With an expected workforce of 188,000 people, this job loss will take the industry back to 2014 levels as a result of the COVID-19 crisis. read on

Five reasons why Covid pandemic is perfect time to introduce carbon fee-and-dividend schemes
Such a move would boost flagging economies and the fight against climate change while putting more money into people’s pockets, write Gerard Reid and Gerard Wynn read on

Global solar growth 18% lower than expected as COVID hits market: Wood Mac
Global solar construction and development growth is slowing as countries enforce unprecedented Covid-19 lockdowns, according to analysts at Wood Mackenzie who cut their 2020 PV installation forecast by 18% … read on

Coronavirus: Falling power demand is impacting clean energy
Much of the European economy is on some level of lockdown, with citizens and businesses in Italy, Spain, France, Germany and the United Kingdom all forced to curtail their usual habits, stay inside and wait until the coronavirus pandemic is under some sort of control. No one knows quite how long these measures could be in place, of course, but in the meantime, the sudden downturn in economic activity that has plunged much of Europe and the rest of the world … read on

Climate Change Push Fuels Split On Coronavirus Stimulus
Clean energy and climate advocates say the huge stimulus bill Congress is negotiating should address not only the economy, but also climate change. But a split over that appears to have contributed to delays in passing the bill. read on

Inside Clean Energy: Coronavirus May Mean Halt to Global Solar Gains—For Now
In the middle of a public health emergency, it’s difficult to think about much of anything besides keeping everyone safe. But we also need to look ahead at the potential economic effects of this crisis on the transition to clean energy. With that in mind, we are getting a better idea of what coronavirus means for the growth of solar power in the near future. read on

Visit our Coronavirus Resource Center

We have created this resource center as a central way to keep you informed of the steps we are taking at this time, and offer you some additional resources and information to help your organization during these difficult times. Our team at blum will stay focused on answering your most pressing questions regarding your business including updates on HR policies, tax deadlines, SBA loan availability, cyber and internal controls, productivity and efficiency, work at home capabilities and security,  business modeling and more. In addition, we will continue to provide timely updates as federal and state officials provide guidance and enact measures.

Additional COVID-19 Resources